News & Media

Take a look inside our world

Feature stories

Meet the Expert: Ivana Šoljić Jerbić

Meet the Expert: Ivana Šoljić Jerbić

Meet the Expert: Sebastian Horn

Meet the Expert: Sebastian Horn

Spreading HOPE: Teva’s work to improve global access to medicine

Spreading HOPE: Teva’s work to improve global access to medicine

Meet the Expert: Janet Vaughn, Vice President, Regulatory Affairs, North America Generics

Meet the Expert: Janet Vaughn, Vice President, Regulatory Affairs, North America Generics

Meet Marcos Almendras, Teva Chile employee for 49 years!

Meet Marcos Almendras, Teva Chile employee for 49 years!

Meet Sarika Navara, Teva Israel employee for 46 years!

Meet Sarika Navara, Teva Israel employee for 46 years!

Meet József Szendi, Teva Hungary employee for 49 years!

Meet József Szendi, Teva Hungary employee for 49 years!

Teva: Supporting Pride and the LGBTQ+ Community

Teva: Supporting Pride and the LGBTQ+ Community

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Press Releases

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congre...

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 20

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatme...

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment fo

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be ...

Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be prese

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazi...

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) T

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion A...

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across

Teva Reports Second Quarter 2021 Financial Results

Teva Reports Second Quarter 2021 Financial Results

Teva Announces Changes to Executive Management Team

Teva Announces Changes to Executive Management Team

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 2...

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 20

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Ja...

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan f

Connect with us on social media


Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

+972-3-9187869
Yonatan.Beker@tevapharm.com

Cedric Jungpeter

Corporate Communications International Markets

+972-54-8887729
Cedric.Jungpeter@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com